Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences IncfiledCriticalHuman Genome Sciences Inc
Priority to NZ333515ApriorityCriticalpatent/NZ333515A/en
Priority claimed from PCT/US1996/010561external-prioritypatent/WO1997048807A1/en
Publication of NZ333515ApublicationCriticalpatent/NZ333515A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The application concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine b-15 protein. Chemokine b-15 polypeptides are also provided. The application further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.
NZ333515A1996-06-171996-06-17Polynucleotide encoding a human chemokine beta-15 use in treatment of thymus related diseases
NZ333515A
(en)
Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins